Tanner EJ - Search Results

1

Outcomes of primary surgical cytoreduction in patients with BRCA-associated high-grade serous ovarian carcinoma.

Hyman DM, Long KC, Tanner EJ, Grisham RN, Arnold AG, Bhatia J, Phillips MF, Spriggs DR, Soslow RA, Kauff ND, Levine DA. Hyman DM, et al. Among authors: tanner ej. Gynecol Oncol. 2012 Aug;126(2):224-8. doi: 10.1016/j.ygyno.2012.05.001. Epub 2012 May 8. Gynecol Oncol. 2012. PMID: 22579790 Free PMC article.

2

Surveillance for the detection of recurrent ovarian cancer: survival impact or lead-time bias?

Tanner EJ, Chi DS, Eisenhauer EL, Diaz-Montes TP, Santillan A, Bristow RE. Tanner EJ, et al. Gynecol Oncol. 2010 May;117(2):336-40. doi: 10.1016/j.ygyno.2010.01.014. Epub 2010 Feb 12. Gynecol Oncol. 2010. PMID: 20153027

3

A microRNA survival signature (MiSS) for advanced ovarian cancer.

Shih KK, Qin LX, Tanner EJ, Zhou Q, Bisogna M, Dao F, Olvera N, Viale A, Barakat RR, Levine DA. Shih KK, et al. Among authors: tanner ej. Gynecol Oncol. 2011 Jun 1;121(3):444-50. doi: 10.1016/j.ygyno.2011.01.025. Epub 2011 Feb 26. Gynecol Oncol. 2011. PMID: 21354599

4

The role of cytoreductive surgery for newly diagnosed advanced-stage uterine carcinosarcoma.

Tanner EJ, Leitao MM Jr, Garg K, Chi DS, Sonoda Y, Gardner GJ, Barakat RR, Jewell EL. Tanner EJ, et al. Gynecol Oncol. 2011 Dec;123(3):548-52. doi: 10.1016/j.ygyno.2011.08.020. Epub 2011 Sep 25. Gynecol Oncol. 2011. PMID: 21945551

5

Patterns of first recurrence following adjuvant intraperitoneal chemotherapy for stage IIIC ovarian cancer.

Tanner EJ, Black DR, Zivanovic O, Kehoe SM, Dao F, Konner JA, Barakat RR, Lichtman SM, Levine DA. Tanner EJ, et al. Gynecol Oncol. 2012 Jan;124(1):59-62. doi: 10.1016/j.ygyno.2011.09.011. Epub 2011 Oct 7. Gynecol Oncol. 2012. PMID: 21982046

6

Impact of operative start time on surgical outcomes in patients undergoing primary cytoreduction for advanced ovarian cancer.

Tanner EJ, Long KC, Zhou Q, Brightwell RM, Gardner GJ, Abu-Rustum NR, Leitao MM Jr, Sonoda Y, Barakat RR, Iasonos A, Chi DS. Tanner EJ, et al. Gynecol Oncol. 2012 Jul;126(1):58-63. doi: 10.1016/j.ygyno.2012.04.014. Epub 2012 Apr 13. Gynecol Oncol. 2012. PMID: 22507533 Free PMC article.

7

High grade undifferentiated uterine sarcoma: surgery, treatment, and survival outcomes.

Tanner EJ, Garg K, Leitao MM Jr, Soslow RA, Hensley ML. Tanner EJ, et al. Gynecol Oncol. 2012 Oct;127(1):27-31. doi: 10.1016/j.ygyno.2012.06.030. Epub 2012 Jun 26. Gynecol Oncol. 2012. PMID: 22750260

8

Parenchymal splenic metastasis is an independent negative predictor of overall survival in advanced ovarian, fallopian tube, and primary peritoneal cancer.

Tanner EJ, Long KC, Feffer JB, Leitao MM Jr, Abu-Rustum NR, Barakat RR, Chi DS, Gardner GJ. Tanner EJ, et al. Gynecol Oncol. 2013 Jan;128(1):28-33. doi: 10.1016/j.ygyno.2012.09.019. Epub 2012 Sep 25. Gynecol Oncol. 2013. PMID: 23017819

9

Management of uterine adenosarcomas with and without sarcomatous overgrowth.

Tanner EJ, Toussaint T, Leitao MM Jr, Hensley ML, Soslow RA, Gardner GJ, Jewell EL. Tanner EJ, et al. Gynecol Oncol. 2013 Apr;129(1):140-4. doi: 10.1016/j.ygyno.2012.12.036. Epub 2012 Dec 30. Gynecol Oncol. 2013. PMID: 23283300

10

Optimal (≤1 cm) but visible residual disease: is extensive debulking warranted?

Barlin JN, Long KC, Tanner EJ, Gardner GJ, Leitao MM Jr, Levine DA, Sonoda Y, Abu-Rustum NR, Barakat RR, Chi DS. Barlin JN, et al. Among authors: tanner ej. Gynecol Oncol. 2013 Aug;130(2):284-8. doi: 10.1016/j.ygyno.2013.05.006. Epub 2013 May 11. Gynecol Oncol. 2013. PMID: 23672929

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

91 results

Search Page

Filters